![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CENPT |
Gene summary for CENPT |
![]() |
Gene information | Species | Human | Gene symbol | CENPT | Gene ID | 80152 |
Gene name | centromere protein T | |
Gene Alias | C16orf56 | |
Cytomap | 16q22.1 | |
Gene Type | protein-coding | GO ID | GO:0000278 | UniProtAcc | B3KPB2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
80152 | CENPT | LZE4T | Human | Esophagus | ESCC | 2.21e-10 | 3.26e-01 | 0.0811 |
80152 | CENPT | LZE7T | Human | Esophagus | ESCC | 9.03e-11 | 3.28e-01 | 0.0667 |
80152 | CENPT | LZE8T | Human | Esophagus | ESCC | 5.20e-05 | 1.29e-01 | 0.067 |
80152 | CENPT | LZE22D1 | Human | Esophagus | HGIN | 4.18e-03 | 1.66e-01 | 0.0595 |
80152 | CENPT | LZE24T | Human | Esophagus | ESCC | 2.81e-15 | 3.96e-01 | 0.0596 |
80152 | CENPT | P1T-E | Human | Esophagus | ESCC | 1.21e-11 | 5.98e-01 | 0.0875 |
80152 | CENPT | P2T-E | Human | Esophagus | ESCC | 1.40e-22 | 3.57e-01 | 0.1177 |
80152 | CENPT | P4T-E | Human | Esophagus | ESCC | 4.77e-17 | 3.77e-01 | 0.1323 |
80152 | CENPT | P5T-E | Human | Esophagus | ESCC | 4.48e-15 | 1.99e-01 | 0.1327 |
80152 | CENPT | P8T-E | Human | Esophagus | ESCC | 5.25e-27 | 5.33e-01 | 0.0889 |
80152 | CENPT | P9T-E | Human | Esophagus | ESCC | 3.42e-04 | 1.50e-01 | 0.1131 |
80152 | CENPT | P10T-E | Human | Esophagus | ESCC | 1.64e-21 | 2.02e-01 | 0.116 |
80152 | CENPT | P11T-E | Human | Esophagus | ESCC | 2.41e-14 | 4.31e-01 | 0.1426 |
80152 | CENPT | P12T-E | Human | Esophagus | ESCC | 1.35e-25 | 3.10e-01 | 0.1122 |
80152 | CENPT | P15T-E | Human | Esophagus | ESCC | 2.61e-13 | 2.64e-01 | 0.1149 |
80152 | CENPT | P16T-E | Human | Esophagus | ESCC | 4.79e-15 | 1.92e-01 | 0.1153 |
80152 | CENPT | P17T-E | Human | Esophagus | ESCC | 2.08e-09 | 3.98e-01 | 0.1278 |
80152 | CENPT | P19T-E | Human | Esophagus | ESCC | 2.29e-07 | 5.26e-01 | 0.1662 |
80152 | CENPT | P20T-E | Human | Esophagus | ESCC | 6.61e-09 | 2.64e-01 | 0.1124 |
80152 | CENPT | P21T-E | Human | Esophagus | ESCC | 1.26e-15 | 2.83e-01 | 0.1617 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00070593 | Esophagus | HGIN | chromosome segregation | 71/2587 | 346/18723 | 3.47e-04 | 5.62e-03 | 71 |
GO:000705911 | Esophagus | ESCC | chromosome segregation | 238/8552 | 346/18723 | 1.72e-18 | 1.82e-16 | 238 |
GO:00513831 | Esophagus | ESCC | kinetochore organization | 21/8552 | 23/18723 | 5.69e-06 | 5.90e-05 | 21 |
GO:00345081 | Esophagus | ESCC | centromere complex assembly | 25/8552 | 30/18723 | 2.45e-05 | 2.09e-04 | 25 |
GO:00513821 | Esophagus | ESCC | kinetochore assembly | 16/8552 | 18/18723 | 1.78e-04 | 1.15e-03 | 16 |
GO:00070592 | Oral cavity | OSCC | chromosome segregation | 206/7305 | 346/18723 | 5.82e-15 | 3.76e-13 | 206 |
GO:0051383 | Oral cavity | OSCC | kinetochore organization | 18/7305 | 23/18723 | 1.47e-04 | 1.04e-03 | 18 |
GO:0034508 | Oral cavity | OSCC | centromere complex assembly | 21/7305 | 30/18723 | 5.75e-04 | 3.30e-03 | 21 |
GO:0051382 | Oral cavity | OSCC | kinetochore assembly | 14/7305 | 18/18723 | 9.51e-04 | 4.96e-03 | 14 |
GO:00070591 | Oral cavity | LP | chromosome segregation | 117/4623 | 346/18723 | 7.61e-05 | 9.91e-04 | 117 |
GO:00070595 | Thyroid | PTC | chromosome segregation | 146/5968 | 346/18723 | 2.99e-05 | 2.87e-04 | 146 |
GO:000705913 | Thyroid | ATC | chromosome segregation | 183/6293 | 346/18723 | 8.03e-14 | 4.23e-12 | 183 |
GO:00513833 | Thyroid | ATC | kinetochore organization | 18/6293 | 23/18723 | 1.47e-05 | 1.39e-04 | 18 |
GO:00513823 | Thyroid | ATC | kinetochore assembly | 15/6293 | 18/18723 | 2.06e-05 | 1.85e-04 | 15 |
GO:00345083 | Thyroid | ATC | centromere complex assembly | 20/6293 | 30/18723 | 2.18e-04 | 1.43e-03 | 20 |
GO:00718242 | Thyroid | ATC | protein-DNA complex subunit organization | 103/6293 | 241/18723 | 1.84e-03 | 9.03e-03 | 103 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CENPT | SNV | Missense_Mutation | novel | c.1080N>T | p.Glu360Asp | p.E360D | Q96BT3 | protein_coding | deleterious(0.04) | benign(0.058) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CENPT | SNV | Missense_Mutation | novel | c.966N>T | p.Glu322Asp | p.E322D | Q96BT3 | protein_coding | tolerated(0.58) | benign(0.031) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CENPT | SNV | Missense_Mutation | rs540685212 | c.758N>G | p.Asn253Ser | p.N253S | Q96BT3 | protein_coding | tolerated(1) | benign(0) | TCGA-AX-A06D-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | PD |
CENPT | SNV | Missense_Mutation | novel | c.1214N>A | p.Pro405His | p.P405H | Q96BT3 | protein_coding | deleterious(0.05) | benign(0.16) | TCGA-AX-A0IZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CENPT | SNV | Missense_Mutation | rs770581188 | c.641N>A | p.Arg214His | p.R214H | Q96BT3 | protein_coding | tolerated(0.05) | benign(0.18) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CENPT | SNV | Missense_Mutation | novel | c.535N>G | p.Asn179Asp | p.N179D | Q96BT3 | protein_coding | tolerated(0.16) | benign(0.311) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
CENPT | SNV | Missense_Mutation | novel | c.313N>T | p.Pro105Ser | p.P105S | Q96BT3 | protein_coding | tolerated(0.07) | probably_damaging(0.999) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CENPT | SNV | Missense_Mutation | c.1235G>A | p.Arg412Gln | p.R412Q | Q96BT3 | protein_coding | tolerated(0.81) | benign(0.003) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CENPT | SNV | Missense_Mutation | rs543219989 | c.1562N>A | p.Arg521Gln | p.R521Q | Q96BT3 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CENPT | SNV | Missense_Mutation | c.1235N>A | p.Arg412Gln | p.R412Q | Q96BT3 | protein_coding | tolerated(0.81) | benign(0.003) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |